Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of “Moderate Buy” by Brokerages

Sotera Health Company (NASDAQ:SHC) has received an average rating of “Moderate Buy” from the eleven analysts that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $20.2857.

A number of research firms recently commented on SHC. Citigroup increased their target price on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. Piper Sandler reiterated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, June 5th. They issued a “buy” rating and a $20.00 price target for the company. Finally, Barclays reduced their price target on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 15.36% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

Large investors have recently bought and sold shares of the company. CenterBook Partners LP raised its position in Sotera Health by 94.1% during the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock worth $2,673,000 after buying an additional 73,473 shares during the last quarter. Capricorn Fund Managers Ltd purchased a new position in Sotera Health during the 4th quarter worth $7,936,000. Nordea Investment Management AB acquired a new position in shares of Sotera Health during the 4th quarter worth $1,908,000. Exchange Traded Concepts LLC acquired a new position in shares of Sotera Health during the 4th quarter worth $7,739,000. Finally, Retirement Systems of Alabama grew its stake in shares of Sotera Health by 16.9% during the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock worth $4,391,000 after purchasing an additional 35,974 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Down 1.2%

NASDAQ SHC opened at $16.04 on Wednesday. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The firm has a 50 day moving average of $15.66 and a two-hundred day moving average of $16.36. The stock has a market capitalization of $4.57 billion, a PE ratio of 39.12 and a beta of 1.79. Sotera Health has a 52 week low of $10.80 and a 52 week high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s revenue was up 10.0% on a year-over-year basis. During the same period last year, the firm posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, research analysts expect that Sotera Health will post 0.86 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.